Clinical Characteristics, Management, and Outcomes of 19 Nonpediatric Patients with Desmoplastic Small Round Cell Tumor: A Cohort of Brazilian Patients

الملخص EN

Desmoplastic small round cell tumor (DSRCT) is a rare and aggressive mesenchymal malignancy, usually affecting young males.

There is no consensus on the best therapeutic approach.

We seek to characterize a cohort of nonpediatric patients with DSRCT treated at a large Brazilian cancer center.

We performed a retrospective analysis of patients with histologically confirmed DSRCT referred to our institution (2007–2020).

Clinical and imaging data were extracted and summarized with descriptive statistics.

Survival analyses were conducted by the Kaplan–Meier method and compared with the log-rank test.

We included 19 patients with DSRCT, the median age at diagnosis was 26 years (range: 15–41 years), and 68% were male.

Ninety percent presented with abdominopelvic masses, and 32% had extra-abdominal metastasis at diagnosis.

Eleven patients (58%) underwent surgery, four patients (21%) received whole abdominal adjuvant radiotherapy, and five patients (26%) had hyperthermic intraperitoneal chemotherapy.

Median OS was 27 months (interquartile range: 18–51 m).

The five-year OS rate was 12%.

Our data confirm the aggressiveness of DSRCT despite intense multimodality treatment.

Outcomes of patients treated in a reference cancer center in a developing country are similar to cancer centers in developed nations.

Multicenter cooperation is urgent to the development of clinical trials and to improve diagnosis and treatment efficacy.